Archive · 19 Jun 2025
Miltenyi Biotec and BIRAC Partner to Boost Cell Therapy in India
Imagine doctors having powerful tools to fix diseases at the source, like changing the instructions inside your cells!
That's what cell and gene therapy is all about.
In India, a big company called Miltenyi Biotec and a government group called BIRAC are teaming up.
They signed an agreement to help India become a leader in this field.
They will train scientists, build new labs, and find ways to treat diseases like cancer and rare illnesses.
They'll also build local centers where patients can receive these advanced treatments.
This is all part of a plan to make these cutting-edge treatments more available in India and help Indian scientists create their own innovative solutions.
Miltenyi Biotec India and BIRAC signed a Letter of Intent (LOI) to advance Cell and Gene Therapy (CGT) in India.
The collaboration aims to build national capabilities and upskill scientific talent in CGT.
The partnership will expand translational research and co-develop studies focusing on next-generation therapies.
They plan to establish Point-of-Care (PoC) CAR-T centers using automated manufacturing platforms.
The initiative supports local innovation and the 'Make in India' mission through domestic production.
- Who
- Miltenyi Biotec India and Biotechnology Industry Research Assistance Council (BIRAC).
- What
- Miltenyi Biotec India and BIRAC signed an LOI to advance cell and gene therapy.
- When
- Signed at the BIO International Convention 2025 in Boston.
- Where
- India, with activities at the BIO International Convention in Boston.
- Why
- To strengthen India's leadership in biotherapeutics and solve unmet medical needs.
- Partners
- Miltenyi Biotec India and BIRAC
- Event
- BIO International Convention 2025
- Location of Convention
- Boston
- Focus
- Cell and Gene Therapy (CGT)
- Goal
- Advance CGT in India
- Key Aspect
- Training and Capacity Building